Searched for
INSULIN FRANCHISE
Biocon CEO forecasts H2 results to outperform H1; company posts 52% fall in Q2 net profit; revenue up 2%Biocon reported a 52% drop in second-quarter net profit due to shipment delays caused by geopolitical issues. The company expects revenue g...- Ramya Krishnan looks fit and radiant at 56. One dietary habit followed by Baahubali star can improve sleep, reduce blood sugar and help you look youngRamya Krishnan looks ageless and at peak fitness at 56. As per reports, the Baahubali star does not rely on surgeries to look beautiful but...
- Kiran Mazumdar-Shaw names niece Claire as successor, targets semaglutide push from FY28; debt cut to $1.1 billionBiocon's Executive Chairperson, Kiran Mazumdar-Shaw, outlined a five-year leadership transition with her niece, Claire Mazumdar, as success...
- Biocon shifts focus to margins, capacity utilisation after expansion phaseBiocon is shifting its strategy to focus on capacity utilization, margin expansion, and improved returns after significant investments in g...
- History tells us ‘Hold’ is equal to wealth creation: 11 large- and mid-cap stocks from different sectors with upside potential of up to 37%Because we have the word “Hold ” in the headline, does it mean today’s list only has stocks where the analyst recommendation is “Hold”? No....
- Arvind Kejriwal's health is fine, says Punjab CM Mann after meeting AAP supremo in TiharPunjab CM Bhagwant Mann met Delhi CM Arvind Kejriwal in Tihar jail, discussing campaigning for INDIA bloc candidates. Mann confirmed Kejriw...
- French drugmaker Sanofi looks to spin off its consumer business in IndiaThe leading vaccine maker is working with Bank of America on the demerger process, said the people cited above. About 60% of Sanofi India i...
- High ROE & Net Profit Margin, two key elements of long-term wealth creatorsA high return on equity is a result of two factors. First, the basic nature of the business, there are some businesses that require a const...
- Sanofi's valuations are attractive: Why it is stock pick of weekSanofi India’s management has adopted cost control measures and has lowered promotional spends, which was visible in 2020. Its digital push...
- Stocks in the news: YES Bank, HDIL, Manpasand Beverages, Adani Green and NMDCThe company has filed a police complaint regarding hostile takeover.
- Sell Biocon, target Rs 185: Kotak Institutional EquitiesBiocon is a largecap company, operating in pharmaceuticals and health care sector.
- Stocks in the news: Eveready Ind, Lux Ind, Biocon, Endurance Tech, HDFC and Lakshmi Vilas BankVedanta board has approved second interim dividend of Rs 1.85 per equity share for FY 19.
- Five diabetes drugs in top-10 selling list; overtakes anti-infective, antibiotic medsInsulin brand Human Mixtard, oral formulation Glycomet GP, insulin Lantus, oral formulations Galvus Met and Janumet are now in the top-sell...
- US drugmaker Bristol Myers Squibb out of Biocon’s oral insulin projectBMS had taken a wider decision to sell its entire diabetes franchise to British drug maker AstraZeneca, while narrowing its own focus on de...
- Market may be tentative, opportunities are not: 7 stock ideas to make moneyThe news on the monsoon front is good. The first wave of March quarter results shows early signs of earnings revival in some pockets of Ind...
- AstraZeneca, Dr Reddy's ink diabetes drug distribution pactBoth Riax and Riax M are trademarks of the AstraZeneca group. Dr Reddy's Laboratories will be distributing the two drugs in India.
- Biocon Q4 consolidated net up over two-fold to Rs 248.61 croreBiocon today reported an over two-fold jump in its consolidated net profit to Rs 248.61 crore for the quarter ended March 31, 2013.
- Merck to acquire SmartCells for USD 500 mnDrug-maker Merck & Co has announced that it will buy biotechnology company SmartCells for USD 500 million.
- Pfizer deal shot in arm for BioconAs per the deal, Biocon will conduct clinical development and regulatory filings while Pfizer will get the exclusive rights to market these...
- Biocon signs agreement with BayerBiotech major Biocon Limited announced on Wednesday a licensing agreement with multinational healthcare corporation Bayer HealthCare (BHC) ...
Load More
